Clinical Trials Logo

Refractive Errors clinical trials

View clinical trials related to Refractive Errors.

Filter by:

NCT ID: NCT05713253 Recruiting - Refractive Error Clinical Trials

A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEM

Start date: February 2, 2023
Phase: N/A
Study type: Interventional

This study will be a 2-phase, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation to confirm the safety and effectiveness of the ELITA system.

NCT ID: NCT05670626 Recruiting - Myopia Clinical Trials

Correlation Between Preoperative Refraction and Anterior Segment Parameters With ICL Vault

Start date: December 14, 2022
Phase: N/A
Study type: Interventional

This prospective non-comparative interventional study aims to analyse the pre-operative factors affecting the range of optimal ICL vaulting. the main question is what is the correlation between age, gender, spherical equivalent, white to white, anterior chamber volume and depth and postoperative vault? participants will do preoperative investigations ( specular microscopy, pentacam and biometry ) then refractive surgery (ICL implantation) followed by follow-up visits to assess the post-operative ICL vault and visual outcome.

NCT ID: NCT05637827 Recruiting - Clinical trials for Myopia; Refractive Error

The Initiating Factors of Myopia Among Primary and Secondary School Students in Tianjin

Start date: November 1, 2021
Phase:
Study type: Observational

There was a prospective cohort observational study. Forty hyperopic children, 40 myopic children and 120 emmetropia children were randomly selected from grade 1 to grade 3, and were followed up every six months for 3 years. All patients received cycloplegic refraction examination, ocular biological test, binocular visual function test and a questionnaire related to daily eye habits. A multi-level and multi-dimensional data analysis model was constructed to explore the possible factors affecting the occurrence and development of myopia in children.

NCT ID: NCT05597397 Recruiting - Myopia Clinical Trials

Effect of Repeated Low-Level Red-Light Therapy on Retinal Function and Structure

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to evaluate the effect of repeated low-level red-light (RLRL) therapy on the retinal function and structure among myopic teenagers.

NCT ID: NCT05596682 Recruiting - Presbyopia Clinical Trials

Prospective Multicenter Clinical Study on the Visual and Refractive Outcomes and Safety Outcomes Following Implantation of an AddOn Intraocular Lens in Previously Pseudophakic Eyes

Start date: October 17, 2022
Phase:
Study type: Observational

The purpose of this prospective multicenter clinical study is to evaluate the visual and refractive outcomes and safety outcomes following bilateral implantation of trifocal and/or trifocal toric 1stQ AddOn (Medicontur) intraocular lenses (IOLs) to correct residual refractive errors, astigmatism, and presbyopia in previously pseudophakic eyes.

NCT ID: NCT05583253 Recruiting - Refractive Errors Clinical Trials

Visual Outcome of Vitrectomy After Refractive Surgery

Start date: October 13, 2022
Phase: N/A
Study type: Interventional

Results of retinal detachment surgery may be affected in cases with history of previous intraocular surgery.

NCT ID: NCT05458323 Recruiting - Refractive Errors Clinical Trials

Cognitive Level Enhancement Through Vision Exams and Refraction

CLEVER
Start date: January 19, 2024
Phase: N/A
Study type: Interventional

The investigators aim to conduct a mixed-method study in which a randomised controlled trial (RCT) and a descriptive qualitative study will be conducted. The RCT aims to determine whether free near and distance glasses provided to residents in Hyderabad, India, aged ≥ 60 years, with under- or un- corrected refractive error and normal baseline hearing and cognition (HMSE > 18), can improve quality of life, reduce falls, reduce depression, improve social interaction and physical activity cost-effectively over 36 months. The primary qualitative research aim is to a) contextualize the RCT with information on the milieu and culture in which the trial will be conducted; b) provide data on the lived experiences of older adults with reduced vision in the study area, and c) conduct a process evaluation of the trial. The primary outcome measure is the three-year change in cognition measured by LASI- DAD (Longitudinal Aging Study in India(LASI)- Diagnostic Assessment of Dementia(DAD) global cognitive score. Secondary Outcome Measures: Domain-specific cognitive function (orientation, executive function, language/fluency, memory), quality of life (WHOQOL BREF), self-reported visual functioning (INDVFQ), falls, mobility, depression (PHQ9), glasses compliance, cost-effectiveness (total intervention cost per additional quality-adjusted life years(QALY) gained in the intervention group), social interaction/isolation (Social Networking Index, SNI), self-reported physical activity (GPAQ). An additional secondary outcome will be LASI-DAD global cognitive score analysed by excluding any tests determined pre-hoc to depend on visual acuity.

NCT ID: NCT05449015 Recruiting - Myopia Clinical Trials

Study on the Effect of Two Ways of Cycloplegia on Biological Parameters of Ciliary Muscle

Start date: December 22, 2020
Phase: Phase 4
Study type: Interventional

Atropine has a ciliary muscle-paralysing effect and causes hyperopic drift. Besides, atropine has been proven to slow the progression of myopia. Many studies have suggested that atropine can increase the thickness of the choroid. However, few studies have discussed changes in the ciliary muscle after treatment with atropine or other cycloplegic agents. This study aimed to assess the difference in ciliary muscle morphology before and after two different cycloplegic agents and to analyze the correlation between the changes of ciliary muscle biological parameters and the changes of eye axis, spherical equivalent, lens diopter, choroidal thickness, etc. One hundred and forty-four children would be randomly assigned 1:1 to the 1% atropine group and the tropicamide group. This study might provide clinical evidence for the role of regulatory factors in the occurrence and development of myopia.

NCT ID: NCT05447845 Recruiting - Cataract Clinical Trials

Rapid Computerized Visual Acuity Test

Start date: January 1, 2019
Phase:
Study type: Observational

A novel computerized visual acuity test was developed and tested on both healthy persons and patients with ocular conditions. Visual acuity outcomes of the computerized test will be compared to the Early Treatment Diabetic Retinopathy Study (ETDRS) in measures of reproducibility, accuracy and numbers of questions.

NCT ID: NCT05366543 Recruiting - Error, Refractive Clinical Trials

Errors of Refraction Among Primary School Children

Start date: January 3, 2022
Phase:
Study type: Observational

This study will include primary school children to evalute their refraction and follow those who will wear glasses to detect their compliance. Visual acuity will be measured using autorefractometer after cycloplegic eye drops 3 times and glasses will be prescribed for those who are needed. Follow up of the students to detect their compliance of wearing correction.